PROCEPT BioRobotics
PROCEPT BioRobotics is a medical robotics company behind Aquablation therapy and the HYDROS Robotic System for BPH treatment.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
PROCEPT BioRobotics is a company focused on redefining BPH treatment. Its pioneering solution, Aquablation therapy, is described as the only ultrasound-guided, robotic-assisted, waterjet treatment for BPH across prostates of all shapes and sizes. The company offers the HYDROS Robotic System, a next-generation, AI-powered robotic platform for Aquablation therapy, featuring AI-powered treatment planning with FirstAssist AI, advanced image guidance, robotic resection, and a streamlined workflow. The company states its mission is to revolutionize BPH treatment globally in partnership with urologists by delivering best-in-class robotic solutions.
History
PROCEPT BioRobotics was founded on the belief that there is a better way to treat BPH. Its pioneering solution, Aquablation therapy, emerged from the intersection of medical expertise, technological innovation, and deep empathy for every patient. The company is revolutionizing the treatment of BPH to improve the lives of men around the world.
Products and positioning
Redefining choices in men's health through advanced robotic treatments for BPH.
Aquablation therapy
The only ultrasound-guided, robotic-assisted, waterjet treatment for BPH across prostates of all shapes and sizes.
HYDROS Robotic System
The next-generation, AI-powered platform for Aquablation therapy, featuring AI-powered treatment planning with FirstAssist AI, advanced image guidance, robotic resection, and a streamlined workflow.
Sources6 sources
- 1Robotic Treatments for Men's Health | PROCEPT BioRoboticsprocept-biorobotics.com
- 2Innovators in BPH Treatment | About PROCEPT BioRoboticsprocept-biorobotics.com
- 3HYDROS Robotic System for BPH | PROCEPT BioRobotics®procept-biorobotics.com
- 4PROCEPT BioRoboticswikidata.org
- 5PRCT FINAL DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit - PR Newswirenews.google.com
- 6PRCT Investor Announcement: PROCEPT BioRobotics Sued on behalf of Investors to Recover Losses after Artificially Inflated Revenue Leads to 18% Stock Dropprnewswire.com
Cite this profile: Cite the canonical profile. /brand-wiki/procept-biorobotics · Editorial policy · How profiles are compiled